Rockefeller Capital Management L.P. Boosts Holdings in SPDR S&P Biotech ETF $XBI

Rockefeller Capital Management L.P. boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 44.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 236,057 shares of the exchange traded fund’s stock after buying an additional 72,636 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in SPDR S&P Biotech ETF were worth $28,782,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Banque Pictet & Cie SA raised its holdings in SPDR S&P Biotech ETF by 24.1% in the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock worth $7,910,000 after purchasing an additional 12,595 shares during the period. Apella Capital LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $490,000. Keystone Investors PTE Ltd. purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $12,022,000. Mirae Asset Global Investments Co. Ltd. increased its position in SPDR S&P Biotech ETF by 106.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,570 shares of the exchange traded fund’s stock worth $3,240,000 after buying an additional 13,729 shares in the last quarter. Finally, Greystone Financial Group LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $658,000.

SPDR S&P Biotech ETF Stock Up 3.7%

XBI stock opened at $145.86 on Tuesday. The business’s 50-day moving average price is $133.84 and its 200-day moving average price is $127.95. The stock has a market cap of $9.31 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a twelve month low of $80.90 and a twelve month high of $146.77.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.